Literature DB >> 12039502

Arterial repair after stenting and the effects of GM6001, a matrix metalloproteinase inhibitor.

Chris Li1, Warren J Cantor, Nafiseh Nili, Ranga Robinson, Louis Fenkell, Yen Le Tran, Heather A Whittingham, Winston Tsui, Asim N Cheema, John D Sparkes, Kenneth Pritzker, Daniel E Levy, Bradley H Strauss.   

Abstract

OBJECTIVES: This study compared the extracellular matrix (ECM) and cellular responses after stenting to balloon angioplasty (BA) and to determine the late effects of matrix metalloproteinase (MMP) inhibition on arterial repair after stenting.
BACKGROUND: Although stenting is the predominant form of coronary intervention, there is limited understanding of the early and late arterial response.
METHODS: In a double-injury rabbit model, adjacent iliac arteries in 87 animals received BA (3.0 mm diameter) or stenting (3.0 mm NIR). Rabbits were treated for 1 week postprocedure with either GM6001 (100 mg/kg per day), an MMP inhibitor or placebo and sacrificed at 1 week or at 10 weeks' postprocedure. Arteries were analyzed for morphometry, collagen content, gelatinase activity, cell proliferation and DNA content.
RESULTS: Stented arteries had significant increases in collagen content (2-fold) at 10 weeks compared to BA-treated arteries. At one week, overall gelatinase activity was increased >2-fold in stented arteries, with both 72 kD and 92 kD gelatinase activity. Stented arteries also had increases in both intimal DNA content (1.5-fold) and absolute cell proliferation (4-fold). Compared to placebo, GM6001 significantly inhibited intimal hyperplasia and intimal collagen content, and it increased lumen area in stented arteries without effects on proliferation rates.
CONCLUSIONS: Stenting causes a more vigorous ECM and MMP response than BA, which involves all layers of the vessel wall. Inhibition by MMP blocks in-stent intimal hyperplasia and offers a novel approach to prevent in-stent restenosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12039502     DOI: 10.1016/s0735-1097(02)01873-9

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  11 in total

Review 1.  MMPs as therapeutic targets--still a viable option?

Authors:  Barbara Fingleton
Journal:  Semin Cell Dev Biol       Date:  2007-07-06       Impact factor: 7.727

2.  Matrix metalloproteinases and cardiovascular diseases.

Authors:  A Papazafiropoulou; N Tentolouris
Journal:  Hippokratia       Date:  2009-04       Impact factor: 0.471

3.  Preinterventional peak monocyte count and in-stent intimal hyperplasia after coronary stent implantation in human coronary arteries.

Authors:  Young Joon Hong; Myung Ho Jeong; Sang Yup Lim; Sang Rok Lee; Kye Hun Kim; Il Suk Sohn; Hyung Wook Park; Ju Han Kim; Weon Kim; Youngkeun Ahn; Jeong Gwan Cho; Jong Chun Park; Jung Chaee Kang
Journal:  Clin Cardiol       Date:  2005-11       Impact factor: 2.882

4.  A longitudinal immunohistochemical study of the healing of experimental aneurysms after embolization with platinum coils.

Authors:  D Dai; Y H Ding; R Kadirvel; M A Danielson; D A Lewis; H J Cloft; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2006-04       Impact factor: 3.825

5.  Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice.

Authors:  Monica Garcia-Alloza; Claudia Prada; Carli Lattarulo; Sara Fine; Laura A Borrelli; Rebecca Betensky; Steven M Greenberg; Matthew P Frosch; Brian J Bacskai
Journal:  J Neurochem       Date:  2009-04-08       Impact factor: 5.372

6.  Regulation of thrombomodulin expression and release in human aortic endothelial cells by cyclic strain.

Authors:  Fiona A Martin; Alisha McLoughlin; Keith D Rochfort; Colin Davenport; Ronan P Murphy; Philip M Cummins
Journal:  PLoS One       Date:  2014-09-19       Impact factor: 3.240

7.  Sphingomyelinases D From Loxosceles Spider Venoms and Cell Membranes: Action on Lipid Rafts and Activation of Endogenous Metalloproteinases.

Authors:  Priscila Hess Lopes; Carmen W van den Berg; Denise V Tambourgi
Journal:  Front Pharmacol       Date:  2020-05-13       Impact factor: 5.810

8.  Doxycycline prevents intimal hyperplasia in vitro and may improve patency of the internal thoracic artery.

Authors:  Vito Mannacio; Luigi Di Tommaso; Anita Antignano; Ettorino Di Tommaso; Paolo Stassano; Carlo Vosa
Journal:  Biomed Res Int       Date:  2013-08-22       Impact factor: 3.411

9.  Arterial stiffness in patients with coronary artery disease: relation with in-stent restenosis following percutaneous coronary intervention.

Authors:  Zrinko Prskalo; Ivica Brizić; Darko Markota; Ivica Markota; Mladen Boban; Monika Tomic; Boris Starcevic
Journal:  BMC Cardiovasc Disord       Date:  2016-06-06       Impact factor: 2.298

10.  Effects of a Matrix Metalloproteinase Inhibitor-Eluting Stent on In-Stent Restenosis.

Authors:  Jian-Bo Song; Jing Shen; Jun Fan; Zhe Zhang; Zheng-Jia Yi; Shuo Bai; Xiao-Lin Mu; Liang Xiao
Journal:  Med Sci Monit       Date:  2020-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.